HealthEquity, Inc. (HQY) — Fair Value Analysis
Base-case fair value (P50): $105.76 · Current price: $88.46 · Verdict: Undervalued
The Verdict on HQY
Based on our Monte Carlo simulations, HEALTHEQUITY INC (HQY) is currently deemed Fairly Valued. While the stock trades at $88.46, our median fair value (P50) stands at $105.76. This suggests a potential +19.6% to reach our simulated median, indicating that the market price aligns reasonably well with its intrinsic value derived from thousands of forward-looking scenarios. The "Fairly Valued" verdict reflects that, while there is a probabilistic upside to $105.76, the full distribution of outcomes suggests the current price is a rational reflection of its risk-adjusted prospects. Investors should consider this context when evaluating HQY's present valuation against potential future returns.
How HQY stacks up against peers
HEALTHEQUITY INC's operational and financial health is currently assessed as "average" when compared to its sector peers. This "average" quality tier suggests that HQY exhibits typical financial stability and operational efficiency within its competitive landscape. Despite the potential +19.6% to our $105.76 estimate, this average quality rating implies that HQY does not present a compelling valuation based on exceptional fundamental strength relative to its industry. The $88.46 reflects a market consensus on a company performing in line with its sector, rather than outperforming or underperforming significantly on key metrics.
What this means for investors
For investors tracking HQY, the "Fairly Valued" assessment, despite the +19.6% to the $105.76 target, suggests a nuanced investment decision. The current trading price of $88.46 does not present a strong undervaluation, nor is it significantly overvalued by our simulations. While a bull case scenario could see HQY approach or exceed $105.76, a downside scenario is also within the simulated range of possibilities. FairCurve’s analysis provides a data-driven perspective on HQY’s intrinsic value, helping investors understand the probabilistic nature of future stock performance relative to $88.46. Sign up for FairCurve to see the full bear/bull distribution and track HQY's fair value as new fundamentals are released.
Frequently Asked Questions
Is HQY overvalued or undervalued right now?
HQY is currently deemed "Fairly Valued." While our median fair value (P50) is $105.76, the current market price of $88.46 suggests it is reasonably priced within its probabilistic range.
What is the bear case and bull case for HQY?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside, is available with a free FairCurve account.
How does FairCurve calculate HQY's fair value?
FairCurve employs Monte Carlo simulation to project HQY's fair value across thousands of forward-looking scenarios, using probabilistic models to derive a range of potential outcomes.
How can I track HQY's fair value as it changes?
You can add HQY to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings reports are released.